Efthalia Angelopoulou

Athens, ESYE31 11528, Greece

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 108 publications

Microglia in Epilepsy: From Molecular Mechanism to Therapeutic Strategy.

Microglia in Epilepsy: From Molecular Mechanism to Therapeutic Strategy.

Journal: Cells
Published: April 09, 2026

Elucidating the Neurobiological Underpinnings of Mild Behavioral Impairment in Tauopathies: Clinical and Molecular Insights.

Elucidating the Neurobiological Underpinnings of Mild Behavioral Impairment in Tauopathies: Clinical and Molecular Insights.

Journal: International journal of molecular sciences
Published: March 14, 2026

Metabolic Dysfunction in Alzheimer's Disease: Brain Glucose Hypometabolism as an Early Precursor to Amyloid and Tau Pathology.

Metabolic Dysfunction in Alzheimer's Disease: Brain Glucose Hypometabolism as an Early Precursor to Amyloid and Tau Pathology.

Journal: Journal of clinical medicine
Published: January 28, 2026

Reframing Dementia Prevention Strategies Aligned with the WHO Global Action Plan: A Structured Narrative Review Focusing on Mild Behavioral Impairment.

Reframing Dementia Prevention Strategies Aligned with the WHO Global Action Plan: A Structured Narrative Review Focusing on Mild Behavioral Impairment.

Journal: Neurology international
Published: November 24, 2025

From mild behavioral impairment-checklist (MBI-C) to MBI-distress (MBI-D): a paired assessment and clinical correlates of domain-specific caregiver distress in MCI due to AD.

From mild behavioral impairment-checklist (MBI-C) to MBI-distress (MBI-D): a paired assessment and clinical correlates of domain-specific caregiver distress in MCI due to AD.

Journal: Frontiers in dementia
Published: October 31, 2025

Monoclonal Antibodies as Therapeutic Agents in Autoimmune and Neurodegenerative Diseases of the Central Nervous System: Current Evidence on Molecular Mechanisms and Future Directions.

Monoclonal Antibodies as Therapeutic Agents in Autoimmune and Neurodegenerative Diseases of the Central Nervous System: Current Evidence on Molecular Mechanisms and Future Directions.

Journal: International journal of molecular sciences
Published: August 15, 2025

Development of a Specialized Telemedicine Protocol for Cognitive Disorders: The TeleCogNition Project in Greece.

Development of a Specialized Telemedicine Protocol for Cognitive Disorders: The TeleCogNition Project in Greece.

Journal: Geriatrics (Basel, Switzerland)
Published: May 25, 2025

Cognitive Decline in Parkinsonism: From Clinical Phenotypes to the Genetic Background.

Cognitive Decline in Parkinsonism: From Clinical Phenotypes to the Genetic Background.

Journal: Biomedicines
Published: May 17, 2025

Predominant right temporal and frontal brain atrophy and progressive behavioral dementia. A case of prion gene mutation (PRNP).

Predominant right temporal and frontal brain atrophy and progressive behavioral dementia. A case of prion gene mutation (PRNP).

Journal: Neurocase
Published: April 12, 2025

The Greek Version of the Mild Behavioral Impairment Checklist (MBI-C): Psychometric Properties in Mild Cognitive Impairment Due to Alzheimer's Disease.

The Greek Version of the Mild Behavioral Impairment Checklist (MBI-C): Psychometric Properties in Mild Cognitive Impairment Due to Alzheimer's Disease.

Journal: Brain sciences
Published: February 25, 2025

Heterozygous p62/SQSTM1 mutation and right temporal variant of frontotemporal dementia: Α case report.

Heterozygous p62/SQSTM1 mutation and right temporal variant of frontotemporal dementia: Α case report.

Journal: Neurocase
Published: December 25, 2024

Peripheral Immune pattern in a genetic cohort of p.A53T alpha-synuclein carriers.

Peripheral Immune pattern in a genetic cohort of p.A53T alpha-synuclein carriers.

Journal: Parkinsonism & related disorders
Published: December 22, 2024
Showing 1-12 of 108

Last Updated: 09/26/2026